Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths. 
This report contains market size and forecasts of Neglected Tropical Diseases Drugs and Vaccine in Global, including the following market information:
Global Neglected Tropical Diseases Drugs and Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Malaria Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Neglected Tropical Diseases Drugs and Vaccine include Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neglected Tropical Diseases Drugs and Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neglected Tropical Diseases Drugs and Vaccine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, by Type, 2021 (%)
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Global Neglected Tropical Diseases Drugs and Vaccine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, by Application, 2021 (%)
Drugs
Vaccines
Global Neglected Tropical Diseases Drugs and Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neglected Tropical Diseases Drugs and Vaccine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Neglected Tropical Diseases Drugs and Vaccine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica